Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 27(13): 6301-6318, 2023 07.
Artigo em Inglês | MEDLINE | ID: mdl-37458647

RESUMO

Smoking cigarettes contributes to lung cancer progression and the development of other respiratory diseases. E-cigs are increasingly being offered to mitigate the harmful effects of traditional cigarettes and eventually for smoke cessation. Because e-cigs do not burn tobacco, it stands to reason that vaping e-liquid is less harmful than inhaling cigarette smoke. This study critically assessed the underlying biological effects of cigarettes and e-Cigs. We searched PubMed databases to elucidate the fundamental, potentially carcinogenic, molecular pathways and the possible effects of cigarettes and e-cigs products on lung cancer progression. Cigarette smoke leads to chronic obstructive pulmonary disease (COPD), while e-cigs have contributed to lung injury. Cigarette smoke and e-cigs increase proinflammatory cytokine expression in cells and affect protein regulation, leading to an increased lung cancer risk. E-cigs are quickly gaining popularity among consumers. Vaping-related diseases and deaths have attracted attention on a global scale. Excessive nicotine levels in e-liquid have the potential to cause severe toxicity, which can lead to neurological and brain damage and respiratory failure, as well as death. Thus, the toxic effects of e-cigs aerosol exposure are essentially identical to that caused by combustible cigarette smoking.


Assuntos
Sistemas Eletrônicos de Liberação de Nicotina , Neoplasias Pulmonares , Produtos do Tabaco , Humanos , Pulmão , Nicotina , Neoplasias Pulmonares/etiologia
2.
Osteoporos Int ; 32(5): 805-816, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33210179

RESUMO

Even though new drugs for the treatment of rheumatoid arthritis (RA) have been developed, methotrexate (MTX) remains a commonly used drug for RA management. In addition to monitoring disease activity during RA treatment, bone erosion should be closely assessed throughout long-term RA management. In this review article, we present a systematic review of MTX effectiveness in reducing the risk of bone erosion. We reviewed randomized controlled trial studies that involved MTX monotherapy or MTX in combination with placebo. Evaluation of the progression of bone erosion was examined by radiographic assessment such as total Sharp score (TSS) or van der Heijde score (SvdH or vdH TSS), joint space narrowing (JSN), erosion score (ERO), and proportion of radiographic nonprogressors. Several key factors were found to influence the response to MTX treatment, such as gene polymorphism. The exact mechanism of the prevention of bone erosion by MTX remains unclear, which warrants future investigations. The variability of RA disease activity in study subjects resulted in variations in the results reported by individual studies. Collective analysis suggests that MTX could slow down the progression of bone erosion based on a radiographic score of less than 0.5-1/year.


Assuntos
Antirreumáticos , Artrite Reumatoide , Antirreumáticos/uso terapêutico , Artrite Reumatoide/complicações , Artrite Reumatoide/tratamento farmacológico , Progressão da Doença , Quimioterapia Combinada , Humanos , Metotrexato/uso terapêutico , Ensaios Clínicos Controlados Aleatórios como Assunto , Resultado do Tratamento
3.
J Neonatal Perinatal Med ; 13(1): 63-69, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31609704

RESUMO

INTRODUCTION: Vitamin D deficiency and anemia are examples of nutritional problems of global health significance. When these health issues effect pregnant women, they may become a threat to the fetus' potention for intrauterine growth. It has been known that the first trimester is the golden period of fetal programming which influences the fetuses and their life after birth. This study was aiming to analyze the association between first trimester maternal vitamin D, serum ferritin, hemoglobin level and neonatal birth weight. METHODS: From July 2016 a prospective cohort of pregnant women had been observed in four cities in West Java, Indonesia. Two hundred ninety four pregnant women were recuited in the first trimester and 203 of them had complete follow up until delivery. Collected data included maternal demography, blood analysis for ferritin, 25(OH) vitamin D in the first trimester of pregnancy and the birth weight of neonates. Associations were analyzed with multiple regression models. RESULTS: Vitamin D deficiency was highly prevalent among pregnant women in this study (approximately 75%) while anemia was found in 7.5 %, a little above the target of 5 %. However, no significant association was found between maternal serum vitamin D, serum ferritin, hemoglobin level in the first trimester and birth weight of the neonates, before and after adjustment for maternal age, pre-pregnancy body mass index, and parity. CONCLUSION: There were no associations found between vitamin D, ferritin, and hemoglobin level in the first trimester and neonatal birth weight. The negative results in this study should not diminish the benefit of nutritional supplementation during pregnancy. The possibility of other explanatory variables that influence these associations warrants further studies.


Assuntos
Anemia/epidemiologia , Peso ao Nascer , Ferritinas/sangue , Hemoglobinas/metabolismo , Complicações Hematológicas na Gravidez/epidemiologia , Deficiência de Vitamina D/epidemiologia , Vitamina D/análogos & derivados , Adulto , Anemia/sangue , Índice de Massa Corporal , Estudos de Coortes , Feminino , Desenvolvimento Fetal , Humanos , Indonésia , Recém-Nascido , Masculino , Gravidez , Complicações na Gravidez/sangue , Complicações na Gravidez/epidemiologia , Complicações Hematológicas na Gravidez/sangue , Primeiro Trimestre da Gravidez , Estudos Prospectivos , Vitamina D/sangue , Deficiência de Vitamina D/sangue , Adulto Jovem
4.
J Clin Pharm Ther ; 40(6): 680-4, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26417664

RESUMO

WHAT IS KNOWN AND OBJECTIVE: Tuberculosis is still a major infectious disease in Indonesia. Patients are treated mostly using fixed-dose combination treatment in primary public health facilities. The incidence of antituberculosis drug-induced liver injury (AT-DILI) is approximately 10% among Indonesian tuberculosis patients who used standard fixed combination regimens during the intensive phase of treatment. However, information regarding genetic polymorphism associated with the increase risk of drug-induced liver injury is still limited. The aim of this study was to investigate pregnane X receptor (PXR) gene polymorphisms as one of the risk factors of AT-DILI. METHODS: In this prospective cohort study, we recruited 106 adult patients diagnosed with pulmonary tuberculosis and treated with category I FDC (fixed-dose combination). The identification of SNP -25385C>T (rs3814055) was conducted by ARMS (amplification refractory mutation system). Hepatotoxicity was defined as ALT and/or AST levels above the normal threshold on the second, fourth and sixth months of monitoring during tuberculosis treatment. RESULTS AND DISCUSSION: The logistic regression analysis showed that patients with the TT genotype of PXR gene (rs3814055) significantly had a greater risk of AT-DILI (OR 8·89; 95% CI 1·36-57·93, P < 0·05), compared with those of wild-type CC genotype. WHAT IS NEW AND CONCLUSION: The result suggests that in Indonesian patients with tuberculosis, the risk of having AT-DILI was associated with TT genotype of the PXR gene.


Assuntos
Antituberculosos/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/genética , Predisposição Genética para Doença/genética , Polimorfismo de Nucleotídeo Único/genética , Receptores de Esteroides/genética , Tuberculose Pulmonar/genética , Adolescente , Adulto , Antituberculosos/uso terapêutico , Feminino , Genótipo , Humanos , Indonésia , Masculino , Pessoa de Meia-Idade , Receptor de Pregnano X , Estudos Prospectivos , Receptores de Esteroides/uso terapêutico , Fatores de Risco , Tuberculose Pulmonar/tratamento farmacológico , Adulto Jovem
5.
J Clin Pharm Ther ; 40(4): 409-12, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25884353

RESUMO

WHAT IS KNOWN AND OBJECTIVE: Off-label medication is often used in the treatment of paediatric patients. However, it should be restricted due to the lack of evidence related to its efficacy and safety. Little is known about the frequency of off-label drug use or the degree of scientific evidence supporting this practice in Indonesia. The aim of this study was to investigate the off-label prescribing practice for paediatric patients in Bandung city, Indonesia. METHODS: We conducted a retrospective and population-based study including 4936 prescriptions written by paediatricians for 0- to 5-year-old patients from 14 selected community pharmacies in 2012 and analysed the off-label uses. RESULTS AND DISCUSSION: Of the total prescriptions, 18.6% contained at least one off-label drug. Furthermore, 7% of the 16 516 prescribed drugs were categorized as off-label. Of all of the prescribed drugs, doxycycline and domperidone were the most prescribed drugs with off-label indications. WHAT IS NEW AND CONCLUSION: This is the first study that shows a significant number of off-label drugs prescribed for children in Indonesia; therefore, efforts should be made to scrutinize under-evaluated off-label prescribing practices that may compromise patient safety.


Assuntos
Uso Off-Label/estatística & dados numéricos , Padrões de Prática Médica/estatística & dados numéricos , Medicamentos sob Prescrição/administração & dosagem , Pré-Escolar , Humanos , Indonésia , Lactente , Recém-Nascido , Medicamentos sob Prescrição/efeitos adversos , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...